Instruction for use: Clenbuterol

Active substance Clenbuterol

ATX Code R03CC13 Clenbuterol

Pharmacotherapeutic group:

Beta-adrenergic agonist

The nosological classification (ICD-10)

J42 Chronic bronchitis, unspecified

recurrent bronchitis, Bronchitis asthma, wheeze bronchitis, chronic Bronchitis, Inflammatory airways disease, bronchi disease, Qatar smoker, Cough in inflammatory diseases of the lung and bronchus, Exacerbation of Chronic Bronchitis, Chronic bronchitis, Chronic obstructive pulmonary disease, Chronical bronchitis, Chronic bronchitis smokers, Chronic spastic bronchitis, allergic Bronchitis

J43 Emphysema

Interstitial emphysema, Emphysema, Chronic lung disease, Chronic obstructive pulmonary disease, Obstructive pulmonary emphysema, Chronic pulmonary emphysema, Chronic obstructive pulmonary emphysema

J44 Other chronic obstructive pulmonary disease

Allergic bronchitis, Bronchitis asthma, Asthmatic bronchitis, wheeze bronchitis, Bronchitis is an obstructive, bronchi disease, Shortness of sputum in acute and chronic respiratory diseases, Cough in inflammatory diseases of the lung and bronchus, Reversible airflow obstruction, Reversible obstructive airway disease, Obstructive bronchitis disease, Obstructive lung disease, Obstructive bronchitis, Spastic bronchitis, Chronic lung disease, Chronic nonspecific lung diseases, Chronic obstructive pulmonary disease, Chronic obstructive bronchitis, Chronic obstructive airway disease, Chronic obstructive pulmonary disease, Restrictive lung pathology

J45 Asthma

Asthma physical effort, status asthmaticus, Bronchial asthma, Asthma lung flow, Bronchial asthma with obstruction of sputum discharge, Bronchial asthma heavy currents, Bronchial asthma physical effort, hypersecretory asthma, Hormone-dependent form of bronchial asthma, Relief of asthma attacks in bronchial asthma, Non-allergic asthma, nocturnal asthma, Exacerbation of asthma, Asthma attacks, Endogenous forms of asthma, Night asthma, Cough with bronchial asthma

Structure and Composition

1 ml of syrup contains clenbuterol hydrochloride 0.001 mg (1 spoon dosing = 5 ml - 0.005 mg); in dark glass bottles of 100 ml complete with a measured glass, in a cardboard bundle one package.

pharmachologic effect

bronchodilator, adrenoagonists

Indications of Clenbuterol

Bronchial asthma, chronic obstructive bronchitis, emphysema, and others. Pulmonary disease with bronchoobstructive syndrome.

Contraindications

Hypersensitivity, thyrotoxicosis, acute phase of myocardial infarction.

Pregnancy and breast-feeding

Contraindications I trimester of pregnancy and just before birth.

Side effects

Tachycardia, extrasystole, lowering blood pressure, headache, anxiety, tremor of the fingers, dry mouth, nausea, skin rash.

Interaction

Beta-blockers reduce or eliminate the effect. It reduces the activity of insulin and sulfonylureas. Increases (mutually) the toxicity of sympathomimetic agents. Against the background of cardiac glycosides and theophylline MAO inhibitors increases the risk of cardiac arrhythmias.

Dosing and Administration

Inside, adults and children over 12 years - 15 ml 2-3 times a day; maintenance dose - 10 ml, 2 times a day.

Children - up to 8 months (body weight 4-8 kg) - 2.5 ml, 8-24 months (body weight 8-12 kg) - 5 ml, 2-4 years (body weight 12-16 kg) - 7.5 ml, 6.4 years (body weight 16-22 kg) - 10 ml, 6-12 years (body weight 22-35 kg) - 15 ml, 2 times a day.

Storage conditions

In a dry, dark place at a temperature no higher than 20 ° C. At a temperature of 15 to 30 ° C.

Keep out of the reach of children.

The shelf life

3 years.

Do not use beyond the expiration date printed on the package.